Matteo Martino

Medicine & Life Sciences

1. Bipolar Disorder 100%
2. Duloxetine Hydrochloride 56%
3. Major Depressive Disorder 29%
4. Neurotransmitter Agents 25%
5. Depression 24%
6. Antidepressive Agents 22%
7. White Matter 21%
8. Diffusion Tensor Imaging 19%
9. Mental Disorders 16%
10. S 20098 15%
11. Raphe Nuclei 15%
12. Thalamus 14%
13. Substantia Nigra 14%
14. Brain 13%
15. Schizophrenia 13%
16. Cognitive Dysfunction 12%
17. Temperament 12%
18. Serotonin 11%
19. Obsessive-Compulsive Disorder 11%
20. Motor Cortex 11%
21. Dopamine 11%
22. Basal Ganglia 9%
23. Zonisamide 7%
24. Th1-Th2 Balance 7%
25. Chronic Progressive Multiple Sclerosis 6%
26. Psychopharmacology 6%
27. Treatment-Resistant Depressive Disorder 6%
28. Anisotropy 6%
29. Electroretinography 6%
30. Magnetic Resonance Imaging 6%
31. Bupropion 6%
32. Psychopathology 6%
33. Receptors, Serotonin, 5-HT3 6%
34. Therapeutics 6%
35. Serotonin Uptake Inhibitors 6%
36. Pharmaceutical Preparations 6%
37. Tinnitus 5%
38. Immunomodulation 5%
39. Treatment Adherence and Compliance 5%
40. Opioid Receptors 5%
41. Nerve Growth Factor 5%
42. Corpus Callosum 5%
43. Brain-Derived Neurotrophic Factor 5%
44. Norepinephrine 5%
45. Gyrus Cinguli 5%
46. Randomized Controlled Trials 5%
47. Cytokines 5%